CRNA: Circio announces outcome of TG01/gemcitabine combination EU patent proceeding
2023-11-24 13:00:06
· The EPO board of appeal moved to revoke the TG01/gemcitabine combination
method of use patent in pancreatic cancer
· The TG01 / gemcitabine combination was discontinued in 2019